Hormonal & Sexual Wellness
PT-141
Melanocortin-receptor agonist (bremelanotide) studied for sexual arousal disorders; one formulation is FDA-approved for a specific indication.
Sexual-arousal researchMelanocortin-pathway studies
How it works in the body
Brain
Sexual Function Pathways
RESEARCH USE ONLYRESEARCH PEPTIDEAvailable following assessmentREGENEXA ASSESSMENT
Vial concentration
PT-141
10 mgThis is a clinician-reviewed research peptide. Pricing is provided as part of an approved, personalized plan after your assessment is reviewed.
Not sure where to start?
Discover what may fit your goals — a short, personalized Regenexa Assessment.
Take Your Assessment →- 🔒 Secure & encrypted checkout
- 📦 Fast, discreet worldwide shipping
- 🧪 Pharmaceutical-grade quality
- 🔬 Research use only
Not sure where to start? Discover what may fit your goals — a short, personalized Regenexa Assessment.Take Your Assessment →
Melanocortin-4 receptor agonist studied for central (brain-mediated) rather than vascular sexual-arousal pathways, distinguishing its research angle from PDE5-inhibitor-class approaches.
Receptors
Melanocortin-4 receptor (MC4R)
Half-life: Approximately 2–3 hours.
Ask Regenexa AI about PT-141
Get plain-language answers on mechanism, evidence and how it compares to other peptides — grounded in Regenexa's verified data.
“What is the safest melanocortin peptide?”Ask Regenexa AI →
Melanotan II
Kisspeptin
Oxytocin